ERNA
Ernexa Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.35
−3.97%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-44.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 1, 2026 | Ratner Elena · director | A-Award | 5,944 | $4.57 |
| Sep 1, 2026 | Polinsky David · director | A-Award | 5,083 | $4.57 |
| Sep 1, 2026 | Bristol James Arthur · director | A-Award | 8,320 | $4.57 |
| Sep 1, 2026 | Luther Sanjeev · director, officer: President and CEO | A-Award | 118,848 | $4.57 |
| Sep 1, 2026 | Cicala Peter · director | A-Award | 5,943 | $4.57 |
| Sep 1, 2026 | Bristol James Arthur · director | A-Award | 5,083 | $4.57 |
| Sep 1, 2026 | Wexler William A. · director | A-Award | 5,943 | $4.57 |
| Sep 1, 2026 | Cicala Peter · director | A-Award | 5,083 | $4.57 |
| Feb 17, 2026 | Cherington Charles · 10 percent owner | Purchase | 4,000,000 | $0.50 |
| Jul 7, 2025 | Gurrola Sandra M · officer: Sr. VP of Finance | M-Exempt | 30 | $0.00 |
| Jun 11, 2025 | Cherington Charles · 10 percent owner | Purchase | 21,241,163 | $0.10 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Purchase | 4,768,783 | $0.00 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Purchase | 1,237,762 | $1.43 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Sale | 0 | $1.92 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Purchase | 5,420,823 | $0.00 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Sale | 3,125,976 | $1.43 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Purchase | 261,756 | $1.43 |
| May 7, 2025 | Cherington Charles · 10 percent owner | Purchase | 1,562,988 | $1.43 |
| Apr 4, 2025 | Cherington Charles · 10 percent owner | Purchase | 3,768,397 | $0.10 |
| Feb 10, 2025 | Cicala Peter · director | A-Award | 51,485 | $0.34 |
| Feb 10, 2025 | Bristol James Arthur · director | A-Award | 72,074 | $0.34 |
| Feb 10, 2025 | Gurrola Sandra M · officer: Sr. VP of Finance | A-Award | 150,000 | $0.34 |
| Feb 10, 2025 | Luther Sanjeev · director, officer: President & CEO | A-Award | 1,123,350 | $0.34 |
| Feb 10, 2025 | Wexler William A. · director | A-Award | 124,533 | $0.34 |
| Jan 14, 2025 | Ratner Elena · director | A-Award | 140,078 | $0.30 |
| Nov 5, 2024 | Cherington Charles · 10 percent owner | Purchase | 1,562,988 | $1.43 |
| Nov 5, 2024 | Cherington Charles · 10 percent owner | Sale | 3,125,976 | $1.43 |
| Nov 5, 2024 | Cherington Charles · 10 percent owner | Purchase | 0 | $0.50 |
| Nov 5, 2024 | Cherington Charles · 10 percent owner | Sale | 0 | $2.86 |
| Nov 5, 2024 | Cherington Charles · 10 percent owner | Purchase | 261,756 | $1.43 |
Institutional positioning
13F filings over the trailing two quarters
New 11Increased 2Reduced 2Sold out 20
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLEICHROEDER LP | New Position | 2,000,000 | May 14, 2026 |
| DAUNTLESS INVESTMENT GROUP, LLC | New Position | 612,443 | May 14, 2026 |
| CI PRIVATE WEALTH, LLC | Reduced | 438,093 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 244,446 | May 15, 2026 |
| XTX TOPCO LTD | New Position | 54,338 | May 15, 2026 |
| WARBERG ASSET MANAGEMENT LLC | New Position | 50,000 | May 7, 2026 |
| JANE STREET GROUP, LLC | New Position | 41,167 | May 12, 2026 |
| CITADEL ADVISORS LLC | New Position | 33,076 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 26,504 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 25,447 | May 8, 2026 |
| UBS GROUP AG | Increased | 21,233 | May 5, 2026 |
| GOLDMAN SACHS GROUP INC | New Position | 16,631 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 15,104 | Sep 2, 2026 |
| SIPPICAN CAPITAL ADVISORS | Unchanged | 10,000 | Apr 23, 2026 |
| BLACKROCK, INC. | Unchanged | 820 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 1, 2026